These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26737239)

  • 1. Medial temporal lobe high resolution magnetic resonance images for the early diagnosis of Alzheimer's disease.
    Brun F; Sensi F; Quartulli R; Rei L; Grucka A; Mancarella V; Chincarini A; Ukmar M; Accardo A; Longo R
    Annu Int Conf IEEE Eng Med Biol Soc; 2015 Aug; 2015():4274-7. PubMed ID: 26737239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medial temporal lobe subregional morphometry using high resolution MRI in Alzheimer's disease.
    Wolk DA; Das SR; Mueller SG; Weiner MW; Yushkevich PA;
    Neurobiol Aging; 2017 Jan; 49():204-213. PubMed ID: 27836336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphometry of medial temporal lobe subregions using high-resolution T2-weighted MRI in ADNI3: Why, how, and what's next?
    Yushkevich PA; Ittyerah R; Li Y; Denning AE; Sadeghpour N; Lim S; McGrew E; Xie L; DeFlores R; Brown CA; Wisse LEM; Wolk DA; Das SR;
    Alzheimers Dement; 2024 Nov; 20(11):8113-8128. PubMed ID: 39279366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Intrinsic Activity of Medial-Temporal Lobe Subregions is Associated with Decreased Cortical Thickness of Medial-Parietal Areas in Patients with Alzheimer's Disease Dementia.
    Pasquini L; Scherr M; Tahmasian M; Myers NE; Ortner M; Kurz A; Förstl H; Zimmer C; Grimmer T; Akhrif A; Wohlschläger AM; Riedl V; Sorg C
    J Alzheimers Dis; 2016; 51(1):313-26. PubMed ID: 26836175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of minimal thickness of the medial temporal lobe with hippocampal volume, maximal and minimal hippocampal length: volumetric approach with horizontal magnetic resonance imaging scans for evaluation of a diagnostic marker for neuroimaging of Alzheimer's disease.
    Uotani C; Sugimori K; Kobayashi K
    Psychiatry Clin Neurosci; 2006 Jun; 60(3):319-26. PubMed ID: 16732748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Training labels for hippocampal segmentation based on the EADC-ADNI harmonized hippocampal protocol.
    Boccardi M; Bocchetta M; Morency FC; Collins DL; Nishikawa M; Ganzola R; Grothe MJ; Wolf D; Redolfi A; Pievani M; Antelmi L; Fellgiebel A; Matsuda H; Teipel S; Duchesne S; Jack CR; Frisoni GB;
    Alzheimers Dement; 2015 Feb; 11(2):175-83. PubMed ID: 25616957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Application of Automatic Segmentation of Medial Temporal Lobe Subregions in Prodromal and Dementia-Level Alzheimer's Disease.
    Gertje EC; Pluta J; Das S; Mancuso L; Kliot D; Yushkevich P; Wolk D
    J Alzheimers Dis; 2016 Oct; 54(3):1027-1037. PubMed ID: 27567809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer assisted diagnosis of Alzheimer's disease using statistical likelihood-ratio test.
    Zheng X; Cawood J; Hayre C; Wang S;
    PLoS One; 2023; 18(2):e0279574. PubMed ID: 36800393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in MRI biomarkers for the diagnosis of Alzheimer's disease.
    Kehoe EG; McNulty JP; Mullins PG; Bokde AL
    Biomark Med; 2014; 8(9):1151-69. PubMed ID: 25402585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic Resonance Imaging and Anatomical Correlation of Human Temporal Lobe Landmarks, in 3D Euclidean Space: A Study of Control and Alzheimer's Disease Subjects.
    Delgado-González JC; Florensa-Vila J; Mansilla-Legorburo F; Insausti R; Artacho-Pérula E
    J Alzheimers Dis; 2017; 57(2):461-473. PubMed ID: 28269774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volumetric GWAS of medial temporal lobe structures identifies an ERC1 locus using ADNI high-resolution T2-weighted MRI data.
    Cong S; Yao X; Huang Z; Risacher SL; Nho K; Saykin AJ; Shen L; ;
    Neurobiol Aging; 2020 Nov; 95():81-93. PubMed ID: 32768867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease.
    Pettigrew C; Soldan A; Sloane K; Cai Q; Wang J; Wang MC; Moghekar A; Miller MI; Albert M;
    Neuroimage Clin; 2017; 16():439-446. PubMed ID: 28879085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CERAD experience, Part VIII: Neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease.
    Davis PC; Gearing M; Gray L; Mirra SS; Morris JC; Edland SD; Lin T; Heyman A
    Neurology; 1995 Jan; 45(1):178-9. PubMed ID: 7824112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease.
    Schmand B; Huizenga HM; van Gool WA
    Psychol Med; 2010 Jan; 40(1):135-45. PubMed ID: 19863841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of an Magnetic Resonance Imaging Acquisition and Review Protocol for Alzheimer's Disease and Related Disorders.
    Asselin A; Potvin O; Bouchard LO; Brisson M; Duchesne S
    Can Assoc Radiol J; 2019 May; 70(2):172-180. PubMed ID: 30894287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiological-Pathological Correlation in Alzheimer's Disease: Systematic Review of Antemortem Magnetic Resonance Imaging Findings.
    Dallaire-Théroux C; Callahan BL; Potvin O; Saikali S; Duchesne S
    J Alzheimers Dis; 2017; 57(2):575-601. PubMed ID: 28282807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Automated algorithm to measure changes in medial temporal lobe volume in Alzheimer disease.
    Kazemifar S; Drozd JJ; Rajakumar N; Borrie MJ; Bartha R;
    J Neurosci Methods; 2014 Apr; 227():35-46. PubMed ID: 24518149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI-guided SPECT measurements of medial temporal lobe blood flow in Alzheimer's disease.
    Julin P; Lindqvist J; Svensson L; Slomka P; Wahlund LO
    J Nucl Med; 1997 Jun; 38(6):914-9. PubMed ID: 9189141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardization of hippocampus volumetry using automated brain structure volumetry tool for an initial Alzheimer's disease imaging biomarker.
    Abrigo J; Shi L; Luo Y; Chen Q; Chu WCW; Mok VCT;
    Acta Radiol; 2019 Jun; 60(6):769-776. PubMed ID: 30185071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between hippocampal morphometry and neuropathologic markers of Alzheimer's disease using 7 T MRI.
    Blanken AE; Hurtz S; Zarow C; Biado K; Honarpisheh H; Somme J; Brook J; Tung S; Kraft E; Lo D; Ng DW; Vinters HV; Apostolova LG
    Neuroimage Clin; 2017; 15():56-61. PubMed ID: 28491492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.